依达拉奉联合三七总皂苷注射液治疗急性脑梗死临床效果分析  

Edaravone Injection Combined PNS Effect of Treatment of Acute Cerebral Infarction

作　　者：文雯[1] 

机构地区：[1]资阳市第一人民医院神经内科,四川资阳641300

出　　处：《中国卫生产业》2011年第10X期15-16,共2页China Health Industry

摘　　要：目的评价依达拉奉与三七总皂苷注射液在治疗急性脑梗死的疗效及安全性方面的对比。方法将符合急性脑梗死条件的患者219例随机分为依达拉奉组(73例)、三七总皂苷(73例)与联合治疗组(73例),进行8周的疗程。结果两药联合治疗的效果优于两药各自单独使用的效果,且无明显的不良反应,P<0.05,差异具有统计学意义。结论依达拉奉与三七总皂苷联合应用对于治疗急性脑梗死的早期康复疗效确切,值得临床推广应用。Objective To evaluate the edaravone injection with the PNS in the treatment of acute cerebral infarction and safety aspects of the comparison.Methods Meet the conditions of the patients with acute cerebral infarction were randomly divided into 219 cases of edaravone group（73 cases）,PNS（73 cases）and combined treatment group（73 cases）,the 8w of treatment.Results The two--drug combination therapy is better than using two separate effects of each drug,and no significant adverse reactions,P〈0.05,statistically significant difference.Conclusion Edaravone in combination with the PNS for the treatment of acute cerebral infarction in the early rehabilitation and effective,worthy of clinical application.

关 键 词：依达拉奉 三七总皂苷 急性脑梗死 效果 

分 类 号：R743.33[医药卫生—神经病学与精神病学]